Updates and Events
CareFirst and Exagen Diagnostics Announce Evidence Development Agreement for AVISE® Lupus Diagnostic Test

August 20, 2018 Source: CareFirst BlueCross BlueShield Press Release CareFirst BlueCross BlueShield (CareFirst) and Exagen Diagnostics, Inc. (Exagen) today announced an agreement to collaborate to study the impact of Exagen’s proprietary AVISE Lupus test.  As part of the agreement, select CareFirst members will have access to the AVISE Lupus test to aid in the differential […] READ MORE

Potential Treatment for Sun Damage Discovered with LRA Funding

August 16, 2018 Exposure to the sun is hard on everyone’s skin, causing cells to die. But skin cells are much more vulnerable in people with lupus.  That reaction is called photosensitivity. A team of scientists led by Theresa Lu, MD, PhD, at Hospital for Special Surgery (HSS) in New York may have discovered why. […] READ MORE

Inflammation Trigger Discovery May Lead to New Treatment

August 2, 2018 Inflammation helps us repair injuries and defeat infections. It’s supposed to shut down once a crisis is over. In people with lupus, however, inflammation persists and can damage the joints, skin, and organs. Researchers have discovered a molecular sensor in cells known as the NLRP3 inflammasome that triggers inflammation. When the inflammasome […] READ MORE

Condolences to Family of Long-Time Donors

Posted July 23, 2018 in New York Times We at the Lupus Research Alliance extend our deepest condolences to the family of Jean Steinberg. She and her late husband Meyer “Mike” along with their entire family have been long-time supporters of our lupus cause, determined to fund the most promising research that can better treat […] READ MORE

Get Inspired!

July 17, 2018 The Lupus Research Alliance New York City Lupus Research Reception featured incredible speakers whose remarks are well worth sharing: Larry Schreiber, President of Empire BlueCross BlueShield; Meggan Mackay, MD, MS, Investigator at the Feinstein Institute for Medical Research; and Kenneth Farber, President & CEO, Lupus Research Alliance. The take-aways are clear – companies fund causes […] READ MORE

Take Survey to Help Advance Clinical Studies for New Lupus Treatments

July 3, 2018 The Lupus Research Alliance, Antidote, and SCORR Marketing are conducting a survey to learn what people with lupus and their caregivers, or care partners, think about clinical research.  Survey participation will take about 20 minutes and your answers are confidential. By answering these questions, you can help us make clinical trials easier for people willing to participate. […] READ MORE

Successful Advocacy Bringing Millions in Research Dollars to Lupus

une 28, 2018 With an overwhelming majority vote of 359 to 49, the House of Representatives just passed a bill to allocate $5 million to the Defense Department’s Congressionally Directed Medical Research Program for lupus in the 2019 budget.  This federal support of lupus research is a result of advocacy by lupus patients, organizations like […] READ MORE

Lupus Research Alliance Investment in Innovation Delivers Results

June 27, 2018 This new issue of the Lupus Research Update (LRU) takes you behind the scenes of some of the most groundbreaking research and how the Lupus Research Alliance raises the funds that enable diverse and accomplished scientists to pioneer new studies in the field. Featured in this LRU, Penn State researcher Dr. Laura […] READ MORE

Learn and connect with our community!